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Abstract This study was conducted to identify the potential relationship between the dietary intake level of soy isofla-
vones and perimenstrual symptomatology. The research design was a cross-sectional study. The sample was
made up of 84 Korean women living in the USA, aged 28–40 years. The Moos Menstrual Distress Question-
naire (MDQ) and the Food Frequency Questionnaire were used as measurement tools. The soy isoflavone
intake was significantly correlated with MDQ scores in the menstrual phase. In conclusion, the beneficial
effect of dietary soy isoflavones on certain menstrual symptoms was established, suggesting that soy isofla-
vones could be one of the dietary factors related to the complexity of premenstrual syndrome (PMS). The pos-
itive effect of soy isoflavones on PMS warrants further study.
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INTRODUCTION
Premenstrual syndrome (PMS) and menstrual distress are
unique to women of reproductive age. As the temporal fluc-
tuation in symptoms is tightly linked with the menstrual
cycle, prior research has suggested that such fluctuations
might be the result of a complex interaction between ovarian
steroids and central neurotransmitters (Mortola, 1998). Pre-
menstrual symptoms occur in 95% of all women of reproduc-
tive age, with 5% of those women suffering from PMS (Ismail
& O’Brien, 2000).
Jefferson (2003) explained that non-pharmacological
interventions, such as a healthy balanced diet, should be
emphasized before resorting to pharmacological treatment
as it helps lessen the symptoms of PMS and menopause. The
consumption of a healthy balanced diet rich in unrefined car-
bohydrates and lean protein foods, low in fats (particularly
saturated fats), and containing a wide variety of fruits and
vegetables should be the goal of every woman. For women
with milder forms of PMS, nutritional management might be
a preferred alternative to pharmacological treatments (Free-
man et al., 2003). Dietary modification as a treatment for
PMS has involved recommendations for foods rich in grains,
vegetables, vitamins, and minerals but low in fat, sodium, caf-
feine, and alcohol (Bussell, 1998; Ismail & O’Brien, 2000;
Bosarge, 2003; Halbreich, 2003). Bussell (2000) suggested the
main aim of a dietary change is to reduce circulating estrogen
and to block its attachment to receptor sites, as well as to
increase serotonin synthesis. One such recommendation is to
increase soy intake as phytestrogens bind to estrogen sites,
thereby decreasing the effects of estrogen.
Prior research has shown that dietary isoflavones can mod-
ulate endocrine status and influence ovarian cyclicity (Ken-
neth et al., 1999). Isoflavones are a class of phytoestrogens
found predominantly in legumes and beans. Soybeans are a
rich source of isoflavones (Vincent & Fitzpatrick, 2000).
Isoflavones can be found in some 300 plants, but are partic-
ularly abundant in soy (Marchelle, 1999). Interest in the role
of dietary phytoestrogens and their effects on women’s
health has dramatically increased over the past decade. In
particular, isoflavone-rich soy foods are now believed to play
a role in alleviating the symptoms of menopause, maintaining
bone density, reducing cholesterol levels, and protecting anti-
oxidant activities (Jefferson, 2003). Although these effects
have been significant concerning menopause, very few ben-
efits of isoflavones have been reported with regard to PMS
symptomatology (Washburn et al., 1999; Vincent & Fitz-
patrick, 2000).
EFFECTS OF ISOFLAVONES ON THE 
MENSTRUAL CYCLE
Studies in rats demonstrate that when phytoestrogens are
administered in doses comparable to dietary levels, they can
induce dramatic uterine growth in a dose-dependent and
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duration-dependent fashion, suggesting an action at the
estrogen receptor site (Whitten et al., 1992). Others have sug-
gested that high-soy diets might lower the levels of bioavail-
able circulating steroids by raising sex hormone-binding
globulin concentrations, as well as suppressing luteinizing
hormone (LH) (Baker et al., 2000).
The consumption of soy isoflavones can influence a
woman’s menstrual cycle experience, as well as affect the
estrogen metabolism in premenopausal women. Several
studies have demonstrated the possible effects of dietary
intervention. For 6 months, Cassidy et al. (1994) gave 69 g of
soy protein (45 mg isoflavones) daily to six western women.
They found that the follicular phase increased by an average
of 2.5 days (P < 0.01). This effect was associated with the sup-
pression of the mid-cycle surges of follicular stimulating
hormone and LH, suggesting an action at the hypothalamic–
pituitary level. Lu et al. (1996) reported that, in premeno-
pausal women, an intake of 960 ml of soy milk/day (≈ 200 mg
of isoflavones) resulted in a 31–81% drop in circulating
estradiol, dependent upon the specific time period in the
menstrual cycle. Barnard et al. (2000) demonstrated that a
low-fat, vegetarian diet could reduce dysmenorrhea and pre-
menstrual symptoms, in association with an increase in serum
sex hormone-binding globulin concentration, perhaps reduc-
ing estrogen activity. Watanabe et al. (2000) studied the
effects of an isoflavone supplement on the hormonal states of
young premenopausal women, observing that menstruation
was prolonged in 60% of the women but reduced in 20%. In
blood analysis, 17 beta estradiols were found to be sup-
pressed throughout the menstrual cycle, while serum hemo-
globin-binding globulin was significantly increased by ≈ 10%.
A growing body of laboratory and clinical evidence sug-
gests that dietary isoflavones might exert their activity in the
menstrual cycle; however, there is little work relating isofla-
vones’ effects on menstrual cycle-related symptoms.
PURPOSE
To overcome the risk of protein deficiency resulting from a
rice-based diet, Koreans traditionally have consumed high
quantities of soybeans and soy foods (Kim et al., 1998). The
approximate dietary isoflavone intake of members of the
Korean population has been estimated to be ≈ 15 mg day−1
(Kim & Kwon, 2001), with soybeans and three traditional soy
foods (tofu, soybean paste, soybean sprouts) composing
> 94% of the total isoflavone intake. It is postulated that such
a diet could influence the ovarian menstrual cycle and, in
turn, potentially influence menstruation-related problems.
As a way to further understand the dietary factors related to
menstrual cycle symptomatology, this study explored the
relationship between perimenstrual symptoms and the
dietary intake level of soy isoflavones among Korean women
living in the USA.
METHODS
A descriptive survey design was utilized to collect cross-
sectional and retrospective data. Data analysis procedures
included descriptive analysis, ANOVA, Pearson’s correlation
coefficient, and stepwise regression using the SPSS computer
program (version 10; SPSS, Chicago, IL, USA).
Sample
A convenience sample of 102 Korean women living in an
urban area of south-eastern Michigan was recruited to par-
ticipate in the study. Women were included if they: (i) were
between 18 and 45 years of age; (ii) had regular menstrual
cycles; and (iii) could understand and write either Korean or
English. Individuals were excluded from the study if they
were: (i) pregnant and/or lactating; (ii) taking medication for
psychiatric or medical treatment; (iii) experiencing a major
gynecologic disorder (i.e. endometriosis or menorrhagia); or
(iv) following a special diet (i.e. weight loss, vegetarian, or
therapeutic). Women were excluded from the present analy-
sis if they did not complete the Food Frequency Question-
naire (FFQ), reducing the total sample size by 18 women.
The final sample size for the present analysis was thus 84.
Data collection procedure
The research protocol was approved by the University of
Michigan Health Sciences Institutional Review Board and
data were collected from April–July 2002. Access to the
study’s participants was accomplished through assistance
from the leaders of Korean community organizations and
churches. Flyers describing the project also were posted in
Korean grocery stores. Community leaders were asked to
make the initial contact with potential participants, briefly
explaining the study to them and obtaining verbal permission
for contact by the researchers. The principal investigator then
contacted each woman by phone or email to make an
appointment at her home or church. During the visit, subjects
read and signed an informed consent form agreeing to par-
ticipate in the study. Each participant received a small gift
($US2) as a token of appreciation for her participation.
The women spent ≈ 30 min completing a questionnaire
regarding their demographics and general menstrual history,




Demographic data were collected regarding menstrual his-
tory, including the age at menarche, the duration and amount
of menstruation, the length and regularity of the menstrual
cycle, and the birth control history (oral contraceptives).
Other data included age, height/weight, smoking status (yes/
no), coffee or caffeine intake (yes/no), and the level of exer-
cise (none: not at all, mild: once/week, moderate: 2–3 times/
week, heavy: > 4–5 times/week).
Moos Menstrual Distress Questionnaire
The MDQ was used to assess premenstrual and menstrual
symptoms (Moos, 1968; 1985). This instrument has been
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widely used in previous PMS studies and demonstrated its
reliability when translated into Korean (Cronbach’s
alpha = 0.98) for use in a study by Kim et al. (2000). In Kim
et al.’s study, 37 items covering six factors from the original
MDQ were employed, focusing on pain, water retention,
autonomic reactions, negative affect, impaired concentra-
tion, and behavioral changes. The participants were asked to
recall the severity of 37 symptoms on a 6-point scale, ranging
from 0 (not present) to 5 (extreme) throughout the menstrual
phases. The reliability of the MDQ was found to be high, as
demonstrated by a Cronbach’s alpha of 0.96.
The usual intake of dietary soy isoflavones
The usual intake of dietary soy isoflavones was estimated
using the FFQ. It was developed by Lee et al. (2000) and
consists of 17 items and focuses on the isoflavone content of
the soy and soy products frequently consumed by Koreans.
This instrument’s validity was demonstrated while studying
the intake of dietary soy isoflavones among Korean women
by Lee (2001). In this study, the consumed foods included
rice with soybean, rice with seasoned soy bean sprouts,
cooked rice with assorted soybean sprouts, soy paste soup
with tofu, soybean paste stew, natto (dambuk) stew, uncur-
dled tofu stew, pan-fried tofu, steamed tofu, braised, fried
soybeans, seasoned soybean sprouts, soup with soybean
sprouts, soft tofu stew, miso, seasoned soybean paste, noo-
dles in soybean broth, and soy milk. The participants were
asked to recall the frequency and consumption levels of 17
foods on a 9-point scale, including “not at all”, “2–3 times/
month”, “once/month”, “once/week”, “twice/week”, “3–
4 times/week”, “5–6 times/week”, “once a day”, and “twice
a day”, with “small”, “moderate”, and “large” amounts,
respectively.
Lee et al. (2000) established an isoflavone content
rating for common Korean foods. They developed a formula
which was also used in this study: I = F × Q × N (where
I = isoflavone intake, F = frequency per day, Q = amount per
serving, and N = isoflavone content). Lee et al. might not
have accounted for isoflavone intake as contained in non-soy
foods nor for potential recall bias regarding food intake.
RESULTS
Characteristics of sample
Of the 102 women recruited for this study, 84 women (82.4%)
provided complete data for analysis. The participating
women ranged in age from 28–40 years, with a mean age of
35.49 years (± 4.92). All 84 women were married, 34%
reported having two children, and 65% reported no history
of oral contraceptive use. The mean age at menarche was
13.3 years (SD = 1.33, range = 10–17), the mean menstrua-
tion cycle length was 29.6 days (SD = 2.72, range = 27–40),
and the mean duration of menstruation was 5.03 days
(SD = 1.19, range = 3–7). Regular menstruation cycles
(within 2–3 days of variation) were reported by 36% of the
women, and 56.8% rated their menstruation amount as
‘moderate’. All the women were non-smokers and 17.6%
reported engaging in moderate exercise 2–3 times/week.
Furthermore, 79.4% reported drinking coffee and 11.8%
reported drinking alcohol. The mean level of soy isoflavone
intake for these subjects was 20.29 mg day−1 (SD = 13.02,
range = 3.12–60.32).
The mean score of the total MDQ results during the pre-
menstrual phase was 34.95 (SD = 30.55, range = 0–109), in
the menstrual phase it was 35.19 (SD = 30.77, range = 0–103),
and in the postmenstrual phase it was 9.49 (SD = 17.47,
range = 0–88). The mean scores of the total MDQ results in
the three phases were significantly different (F = 11.10,
P = 0.000). The mean scores of the six subscales, except for
“impaired concentration”, had statistically significant varia-
tions in the three different menstrual phases (P < 0.005;
Table 1).
Relationships between demographics, level of soy 
isoflavones intake, and Moos Menstrual Distress 
Questionnaire scores
Table 2 shows the correlations between demographics, the
level of soy isoflavone intake, and total MDQ scores. The
isoflavone intake was significantly correlated with the total
MDQ scores in the menstrual phase (r = −0.332, P = 0.044).
The correlation between the level of exercise and the total
Table 1. Mean (SD) and mean differences of six subscale and total Moos Menstrual Distress Questionnaire (MDQ) scores in three phases of
the menstrual cycle (n = 84)
Item Premenstrual Menstrual Postmenstrual F(p)
Pain 8.57 (7.31) 10.05 (7.04) 2.24 (3.58) 16.49 (0.000*)
Water retention 5.00 (4.28) 3.46 (3.73) 0.95 (2.13) 12.63 (0.000*)
Autonomic reaction 3.76 (4.94) 4.78 (5.24) 1.54 (2.97) 5.03 (0.008*)
Negative affect 8.11 (7.51) 6.38 (6.44) 1.62 (3.80) 11.15 (0.000*)
Impaired concentration 4.86 (7.32) 4.62 (7.03) 1.68 (3.89) 2.96 (0.056)
Behavioral changes 4.65 (4.49) 5.89 (5.86) 1.46 (2.69) 9.40 (0.000*)
MDQ (total) 34.95 (30.55) 35.19 (30.77) 9.49 (17.47) 11.10 (0.000*)
* P < 0.05.
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MDQ scores in the menstrual phase was moderately signifi-
cant (r = −0.458, P = 0.004). Age, Body Mass Index, age at
menarche, number of deliveries, number of abortions, length
of menstrual cycle, duration of menstruation, grade of men-
struation, regularity of menstruation, oral contraceptive use,
and coffee & alcohol intake were not significantly correlated
with the total MDQ scores.
Table 3 shows the correlations between the level of soy
isoflavone intake, exercise, and the MDQ subscale scores in
the menstrual phase. The isoflavone intake was significantly
correlated with autonomic reactions (r = −0.337, P = 0.04)
and behavioral changes (r = −0.464, P = 0.004). The exercise
level was significantly correlated with all subscale scores
except water retention (r = −0.370 ≈ −0.525, P < 0.05).
Additionally, to test the strength of the correlation
between exercise and isoflavone intake on the MDQ scores
in the menstrual phase, a stepwise regression was performed.
Of the variance found in the total MDQ scores in the men-
strual phase, 11.4% was accounted for by the level of soy
isoflavone intake and 21.0% by the level of exercise.
DISCUSSION
In general, dietary habits and food intake have an influence
on both the general and reproductive health of women. The
estimation of the consumption of soy-based foods might
be an indicator of a woman’s health status and possibly of
PMS-related factors. Halbreich (2005) explained that general
unspecific improvements in lifestyle, including exercise,
improved self-care, and balanced healthy nutrition, are effec-
tive for the reduction of PMS symptoms.
Mild, significant, and negative associations between soy
isoflavone intake and MDQ scores during the menstrual
phase were found in the course of this study. These associa-
tions explain 11.4% of the menstrual distress symptom
scores. A high intake of soy isoflavones has been shown to
decrease the blood estrogen level in premenopausal women
(Kruzer, 2002), which might be related to the alleviation of
menstrual distress symptoms. Jefferson (2003) found that
foods rich in isoflavones or lignans provide a wide range of
vital nutrients and form an integral part of the healthy, low-
fat, high-fiber diet recommended by dietary experts through-
out the world. However, in a study of Japanese women, the
soy isoflavone intake was not shown to have any significant
relationship with premenstrual and menstrual symptoms
(Nagata et al., 2004).
In terms of this study, further research should be focused
on the mode of action of soy isoflavones and their responsi-
bility for the positive effects, such as autonomic reactions,
behavioral changes, and other effects on menstruation phe-
Table 2. Pearson correlation coefficients between the variables and the total Moos Menstrual Distress Questionnaire score (n = 84)
Variable Mean (SD) or %
r(p) 
Premenstrual Menstrual Postmenstrual
Age (years) 35.49 (4.92) −0.042 (0.81) −0.206 (0.220) −0.204 (0.23)
Body Mass Index 20.58 (2.08) −0.226 (0.18) −0.047 (0.780) −0.170 (0.31)
Age at menarche (years) 13.27 (1.33) −0.135 (0.43) −0.101 (0.550) −0.013 (0.94)
No. of deliveries 1.67 (1.00) 0.052 (0.76) −0.206 (0.220) −0.108 (0.52)
No. of abortions 0.62 (0.92) −0.034 (0.84) −0.037 (0.830) 0.122 (0.47)
Length of menses (cycle) (days) 29.62 (2.72) 0.011 (0.95) −0.222 (0.190) −0.190 (0.26)
Duration of menstruation (days) 5.03 (1.19) −0.096 (0.57) −0.082 (0.630) −0.108 (0.53)
Grade of menses: moderate (%) 56.80 0.078 (0.65) −0.086 (0.610) 0.093 (0.58)
Regularity of menses: within 2–3 days (%) 36.00 0.004 (0.98) 0.050 (0.770) −0.129 (0.45)
Oral contraceptive: no history (%)† 65.00 0.226 (0.18) −0.047 (0.780) 0.044 (0.80)
Coffee drinker (%)† 79.40 0.084 (0.62) −0.032 (0.850) 0.074 (0.67)
Alcohol drinker (%)† 11.80 −0.106 (0.53) 0.061 (0.720) 0.189 (0.26)
Exercise level: moderate (%) 21.60 −0.218 (0.20) −0.458 (0.004*) −0.255 (0.13)
Soy isoflavone intake (mg/day) 20.29 (13.02) −0.156 (0.36) −0.332 (0.044*) −0.012 (0.94)
* P < 0.05. † Correlation is based on a dummy variable.
Table 3. Pearson correlation coefficients between the variables and the Moos Menstrual Distress Questionnaire subscales in the menstrual
phase (n = 84)
Variable Pain Water Autonomic Negative Concentration Behavior
Isoflavone intake −0.314 (0.060) −0.048 (0.78) −0.337 (0.040*) −0.267 (0.110) −0.232 (0.167) −0.464 (0.004*)
Exercise −0.525 (0.001*) −0.164 (0.33) −0.443 (0.006*) −0.370 (0.024*) −0.391 (0.017*) −0.396 (0.015*)
* P < 0.05. Autonomic, autonomic reaction; Behavior, behavioral changes; Concentration, impaired concentration; Negative, negative affects;
Water, water retention.
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nomena. Unfortunately, a comparison to prior research find-
ings was not possible because of the lack of research on
isoflavone intake among women with PMS. Nonetheless,
these results show that soy isoflavone intake might have a
beneficial effect on some menstrual cycle-related symptoms.
The level of exercise showed mild to moderate, significant,
and negative associations with all subscales of the MDQ
scores, except water retention in the menstrual phase, and
accounted for 21% of the total MDQ scores in the menstrual
phase. Doing exercise probably implies a healthy lifestyle,
which is also related positively to the alleviation of menstrual
symptoms. This positive correlation supports earlier findings
of the positive effect of exercise on mood and general health
in regards to PMS (Daugherty, 1998; Ismail & O’Brien, 2000;
Dickerson et al., 2003). Exercise also can reduce fluid reten-
tion, negative affect, bloating, concentration problems, pain,
fear, and guilt (Bosarge, 2003). These effects are also consis-
tent with findings by Aganoff and Boyle (1994), who found
that women who exercised regularly improved in all symp-
toms of PMS on MDQ assesment. However, the impact of
exercise on menstrual symptoms might be overestimated
because of simplified assessment and clustered results such as
none, mild, moderate, and heavy. Therefore, in future
research, the frequency, method, duration, and intensity of
exercise should be clarified for PMS management and study.
The women in this study consumed an average of
20.29 mg day−1 of soy isoflavones, which is similar to that of
middle-aged women in Korea (24.41 mg; Lee et al., 2000). It
is higher than that of the national Korean population survey
(14.88 mg; Kim & Kwon, 2001) and of women in Hong Kong
(19.3 mg; Masdarinec et al., 1998), but lower than that of Jap-
anese women (26.9 mg; Nagata et al., 2004). Japanese women
traditionally consume a diet containing large quantities of
soy products and consequently have a higher intake of isofla-
vones than western women. This difference is assumed to be
the explanation for the longer menstrual cycle experienced
by Japanese women (Jefferson, 2003). In this study, the
length of menstrual cycles among Korean women (mean
= 29.6, SD = 2.72) was found to be similar to that of Japanese
women (mean = 29.4, SD = 3.3; Nagata et al., 2004). Intake
levels of soy isoflavones were not significantly related with
any other variables except MDQ scores, particularly such as
the length of the menstrual cycle. Other researchers had
women maintain a diet containing 45 mg day−1 of isoflavones
for 1 month, which resulted in an increased menstrual cycle
length; however, the study ran for only one menstrual
cycle with only six women (Cassidy et al., 1994). In order to
appropriately compare the Cassidy findings to those of
Nagata, a longer study with a larger sample size would be
required.
It is of particular interest that all of the women in this study
were non-smokers, which seems to be a reflection of a homo-
geneously conservative lifestyle among the women. Further
explanation is needed as to the relationship between smoking
and PMS symptoms.
The level of intake of soy isoflavones in this study was cal-
culated from soy-based foods often consumed by Koreans
and its measurement was dependent upon the subject’s
dietary recall. Kim and Kwon (2001) pointed out the possi-
bility of the underestimation of isoflavone intake as other
non-soy food items presumed to contain soy isoflavones, such
as meat, eggs, or processed foods (e.g. fried noodles, snacks),
were not taken into account. However, as the exact compo-
sition of these foods is not readily available, it is difficult to
reliably estimate the isoflavone content of such foods con-
taining soy flour and soy protein. Nagata et al. (2004) also
used a food frequency questionnaire to assess soy isoflavone
intake levels and they discussed this measurement error,
present in all methods of dietary assessment. Therefore, for a
more accurate assessment of isoflavone intake, it would be
advantageous to include biological measures, such as urinary
isoflavone levels, or other concurrent data, using a food diary.
It is necessary to be able to compare the recalled isoflavone
intake level (using the FFQ) with a urinary isoflavone level
and the actual daily isoflavone intake (using a daily food
diary) in order to confirm the validity of the results.
It is also important to note the method of measurement in
the MDQ. Yu et al. (1996) found the recalled data of PMS
symptoms had been overestimated when compared to con-
current reports. Therefore, it is critical to collect PMS symp-
tom reports over the course of at least one menstruation
cycle for accurate assessment.
This study is limited by potential measurement errors in
dietary recall, PMS symptoms recall, and of isoflavone intake
levels related to unreported food intake on the FFQ. If such
errors occurred, they would contribute to positive or nega-
tive effects in the findings in many aspects.
In conclusion, the beneficial effect of dietary soy isofla-
vones on some menstrual symptoms among Korean women
living in the USA was examined. The findings suggest that
soy isoflavones can be added as one of the relating factors to
PMS phenomena and can further expand our understanding
of the complexity surrounding PMS. In the practise of PMS
assessment and management, it is necessary that diet apprais-
als include a measurement of soy isoflavones intake, and any
relationship between dietary/nutritional imbalances and
PMS symptomatology should be identified. This measure-
ment will lead to an evidence-based recommendation of a
soy isoflavones diet as an integral part of PMS management.
Further study on isoflavones and women’s health concerns
will elucidate their relationship and ultimately will contribute
to the general promotion of health in women. In further
work, a replication study with a large sample of women living
in Korea is necessary, as well as more research into food
intake and its effects on PMS.
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